17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Association of White Matter Rarefaction, Arteriolosclerosis, and Tau With Dementia in Chronic Traumatic Encephalopathy

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Key Points

          Question

          What are the contributions of white matter rarefaction and cerebrovascular disease to dementia in older, deceased individuals who had played football and developed chronic traumatic encephalopathy?

          Findings

          In this cross-sectional study of 180 deceased individuals older than 40 years who had played football and had chronic traumatic encephalopathy, the number of years of football play (a proxy for repetitive head impacts) was associated with worse white matter rarefaction and greater dorsolateral frontal cortex neurofibrillary tangles. White matter rarefaction and neurofibrillary tangles were associated with dementia; arteriolosclerosis was not associated with the number of years of play, but it contributed to dementia.

          Meaning

          In chronic traumatic encephalopathy, dementia is likely a result of neuropathologic changes associated with repetitive head impacts, including white matter rarefaction and phosphorylated tau, in addition to nonhead trauma–associated pathologic changes, such as arteriolosclerosis.

          Abstract

          This cross-sectional study investigates association of white matter rarefaction and cerebrovascular disease with dementia in deceased men older than 40 years who had played football and been found to have chronic traumatic encephalopathy.

          Abstract

          Importance

          Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease associated with repetitive head impacts, including those from US football, that presents with cognitive and neuropsychiatric disturbances that can progress to dementia. Pathways to dementia in CTE are unclear and likely involve tau and nontau pathologic conditions.

          Objective

          To investigate the association of white matter rarefaction and cerebrovascular disease with dementia in deceased men older than 40 years who played football and had CTE.

          Design, Setting, and Participants

          This cross-sectional study involves analyses of data from the ongoing Understanding Neurologic Injury and Traumatic Encephalopathy (UNITE) Study, which is conducted via and included brain donors from the Veterans Affairs–Boston University–Concussion Legacy Foundation brain bank between 2008 and 2017. An original sample of 224 men who had played football and were neuropathologically diagnosed with CTE was reduced after exclusion of those younger than 40 years and those missing data.

          Exposures

          The number of years of football play as a proxy for repetitive head impacts.

          Main Outcomes and Measures

          Neuropathological assessment of white matter rarefaction and arteriolosclerosis severity (on a scale of 0-3, where 3 is severe); number of infarcts, microinfarcts, and microbleeds; and phosphorylated tau accumulation determined by CTE stage and semiquantitative rating of dorsolateral frontal cortex (DLFC) neurofibrillary tangles (NFTs) (none or mild vs moderate or severe). Informant-based retrospective clinical interviews determined dementia diagnoses via diagnostic consensus conferences.

          Results

          A total of 180 men were included. The mean (SD) age of the sample at death was 67.9 (12.7) years. Of 180, 120 [66.7%]) were found to have had dementia prior to death. Moderate to severe white matter rarefaction (84 of 180 [46.6%]) and arteriolosclerosis (85 of 180 [47.2%]) were common; infarcts, microinfarcts, and microbleeds were not. A simultaneous equations regression model controlling for age and race showed that more years of play was associated with more severe white matter rarefaction (β, 0.16 [95% CI, 0.02-0.29]; P = .03) and greater phosphorylated tau accumulation (DLFC NFTs: β, 0.15 [95% CI, 0.004-0.30]; P = .04; CTE stage: β, 0.27 [95% CI, 0.14-0.41]; P < .001). White matter rarefaction (β, 0.16 [95% CI, 0.02-0.29]; P = .03) and DLFC NFTs (β, 0.16 [95% CI, 0.03-0.28]; P = .01) were associated with dementia. Arteriolosclerosis and years of play were not associated, but arteriolosclerosis was independently associated with dementia (β, 0.21 [95% CI, 0.07-0.35]; P = .003).

          Conclusions and Relevance

          Among older men who had played football and had CTE, more years of football play were associated with more severe white matter rarefaction and greater DLFC NFT burden. White matter rarefaction, arteriolosclerosis, and DLFC NFTs were independently associated with dementia. Dementia in CTE is likely a result of neuropathologic changes, including white matter rarefaction and phosphorylated tau, associated with repetitive head impact and pathologic changes not associated with head trauma, such as arteriolosclerosis.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury.

          Since the 1920s, it has been known that the repetitive brain trauma associated with boxing may produce a progressive neurological deterioration, originally termed dementia pugilistica, and more recently, chronic traumatic encephalopathy (CTE). We review 48 cases of neuropathologically verified CTE recorded in the literature and document the detailed findings of CTE in 3 profession althletes, 1 football player and 2 boxers. Clinically, CTE is associated with memory disturbances, behavioral and personality changes, parkinsonism, and speech and gait abnormalities. Neuropathologically, CTE is characterized by atrophy of the cerebral hemispheres, medial temporal lobe, thalamus, mammillary bodies, and brainstem, with ventricular dilatation and a fenestrated cavum septum pellucidum. Microscopically, there are extensive tau-immunoreactive neurofibrillary tangles, astrocytic tangles, and spindle-shaped and threadlike neurites throughout the brain. The neurofibrillary degeneration of CTE is distinguished from other tauopathies by preferential involvement of the superficial cortical layers, irregular patchy distribution in the frontal and temporal cortices, propensity for sulcal depths, prominent perivascular, periventricular, and subpial distribution, and marked accumulation of tau-immunoreactive astrocytes. Deposition of beta-amyloid, most commonly as diffuse plaques, occurs in fewer than half the cases. Chronic traumatic encephalopathy is a neuropathologically distinct slowly progressive tauopathy with a clear environmental etiology.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Clinicopathological Evaluation of Chronic Traumatic Encephalopathy in Players of American Football.

            Players of American football may be at increased risk of long-term neurological conditions, particularly chronic traumatic encephalopathy (CTE).
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cumulative Head Impact Exposure Predicts Later-Life Depression, Apathy, Executive Dysfunction, and Cognitive Impairment in Former High School and College Football Players

              The term "repetitive head impacts" (RHI) refers to the cumulative exposure to concussive and subconcussive events. Although RHI are believed to increase risk for later-life neurological consequences (including chronic traumatic encephalopathy), quantitative analysis of this relationship has not yet been examined because of the lack of validated tools to quantify lifetime RHI exposure. The objectives of this study were: 1) to develop a metric to quantify cumulative RHI exposure from football, which we term the "cumulative head impact index" (CHII); 2) to use the CHII to examine the association between RHI exposure and long-term clinical outcomes; and 3) to evaluate its predictive properties relative to other exposure metrics (i.e., duration of play, age of first exposure, concussion history). Participants included 93 former high school and collegiate football players who completed objective cognitive and self-reported behavioral/mood tests as part of a larger ongoing longitudinal study. Using established cutoff scores, we transformed continuous outcomes into dichotomous variables (normal vs. impaired). The CHII was computed for each participant and derived from a combination of self-reported athletic history (i.e., number of seasons, position[s], levels played), and impact frequencies reported in helmet accelerometer studies. A bivariate probit, instrumental variable model revealed a threshold dose-response relationship between the CHII and risk for later-life cognitive impairment (p < 0.0001), self-reported executive dysfunction (p < 0.0001), depression (p < 0.0001), apathy (p = 0.0161), and behavioral dysregulation (p < 0.0001). Ultimately, the CHII demonstrated greater predictive validity than other individual exposure metrics.
                Bookmark

                Author and article information

                Journal
                JAMA Neurol
                JAMA Neurol
                JAMA Neurol
                JAMA Neurology
                American Medical Association
                2168-6149
                2168-6157
                5 August 2019
                November 2019
                5 August 2020
                : 76
                : 11
                : 1298-1308
                Affiliations
                [1 ]Boston University Alzheimer’s Disease Center and CTE Center, Department of Neurology, Boston University School of Medicine, Boston, Massachusetts
                [2 ]Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts
                [3 ]VA Boston Healthcare System, Boston, Massachusetts
                [4 ]Bedford Veterans Affairs Medical Center, Bedford, Massachusetts
                [5 ]Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts
                [6 ]National Center for Posttraumatic Stress Disorder, VA Boston Healthcare, Boston, Massachusetts
                [7 ]Department of Psychiatry, Boston University School of Medicine, Boston, Massachusetts
                [8 ]Department of Electrical & Computer Engineering, Boston University College of Engineering, Boston, Massachusetts
                [9 ]Department of Ophthalmology, Boston University School of Medicine, Boston, Massachusetts
                [10 ]Department of Biomedical Engineering, Boston University College of Engineering, Boston, Massachusetts
                [11 ]Department of Neurosurgery, Boston University School of Medicine, Boston, Massachusetts
                [12 ]Concussion Legacy Foundation, Boston, Massachusetts
                [13 ]Department of Neurosurgery, Emerson Hospital, Concord, Massachusetts
                [14 ]Braintree Rehabilitation Hospital, Braintree, Massachusetts
                [15 ]Biostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, Massachusetts
                [16 ]Department of Anatomy and Neurobiology, Boston University School of Medicine, Boston, Massachusetts
                [17 ]Center for Biomedical Imaging, Boston University School of Medicine, Boston, Massachusetts
                [18 ]Department of Environmental Health, Boston University School of Public Health, Boston, Massachusetts
                [19 ]Framingham Heart Study, National Heart, Lung, and Blood Institute, Boston, Massachusetts
                [20 ]Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts
                Author notes
                Article Information
                Accepted for Publication: March 28, 2019.
                Corresponding Author : Ann C. McKee, MD, Boston University Alzheimer’s Disease Center and CTE Center, Department of Neurology, Boston University School of Medicine, 72 E Concord St, B7800, Boston, MA 02118 ( amckee@ 123456bu.edu ).
                Published Online: August 5, 2019. doi:10.1001/jamaneurol.2019.2244
                Authors Contributions: Dr McKee had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
                Concept and design: Alosco, Stein, Kowall, Mahar, Stern, Mez, McKee.
                Acquisition, analysis, or interpretation of data: Alosco, Stein, Tripodis, Chua, Kowall, Huber, Goldstein, Cantu, Katz, Palmisano, Martin, Cherry, Killiany, McClean, Au, Alvarez, Stern, Mez, McKee.
                Drafting of the manuscript: Alosco, Stein, Chua, Martin.
                Critical revision of the manuscript for important intellectual content: Alosco, Stein, Tripodis, Chua, Kowall, Huber, Goldstein, Cantu, Katz, Palmisano, Cherry, Mahar, Killiany, McClean, Au, Alvarez, Stern, Mez, McKee.
                Statistical analysis: Alosco, Tripodis, Chua.
                Obtained funding: Kowall, McKee.
                Administrative, technical, or material support: Alosco, Stein, Kowall, Huber, Martin, Cherry, McClean, Au, Alvarez, Stern, Mez, McKee.
                Supervision: Alosco, Stein, Kowall, Huber, Palmisano, Killiany, Stern, Mez, McKee.
                Conflict of Interest Disclosures: Dr Goldstein is a paid consultant to Johnson & Johnson, Janssen Research & Development LLC, and Rebiscan Inc and has received funding from the WWE (World Wrestling Entertainment) and Ivivi Health Sciences. Dr Stern has received research funding from Avid Radiopharmaceuticals Inc, is a member of the Mackey-White Committee of the National Football League Players Association, is a paid consultant to Biogen and Eli Lilly, receives royalties for published neuropsychological tests from Psychological Assessment Resources Inc, and is a member of the Board of Directors of King-Devick Technologies. Dr Cantu is a paid consultant to the National Football League Head Neck and Spine Committee, a vice president and chair of the scientific advisory committee of the National Operating Committee on Standards for Athletic Equipment, and a consultant to the Concussion Legacy Foundation; he also receives royalties from Houghton Mifflin Harcourt and compensation for expert legal opinion to the National Collegiate Athletic Association and National Hockey League and is a member of the Mackey-White Committee of the National Football League Players Association. Dr McKee is a member of the Mackey-White Committee of the National Football League Players Association and reports receiving grants from the National Institutes of Health and Department of Veteran Affairs and other funding from Buoniconti Foundation during the conduct of the study. Dr Alosco reported grants from National Institutes of Health/National Institute of Neurological Disorders and Stroke during the conduct of the study. Dr Katz reported grants from Boston University School of Medicine Department of Neurology during the conduct of the study. Dr Au reported grants from Cohen Veterans Bioscience, Pfizer, Biogen, and Evidation Health and personal fees from Optum Health, outside the submitted work. Dr Stern reported grants from the National Institutes of Health during the conduct of the study; personal fees from Biogen and Eli Lilly outside the submitted work; membership on the board of directors for King-Devick Technologies, with stock options; and royalties for published neuropsychological tests from Psychological Assessment Resources Inc. Dr Mez reported grants from the National Institutes of Health, Department of Defense, Alzheimer’s Association, and Concussion Legacy Foundation during the conduct of the study. No other disclosures were reported.
                Funding/Support: This work was supported by grant funding from the National Institute on Aging (grants AG057902, RF1AG054156, R56AG057768, K23AG046377), National Institute of Neurological Disorders and Stroke (grant K23NS102399), a Department of Veterans Affairs Merit Award (grant I01-CX001038), the Nick and Lynn Buoniconti Foundation, and the National Center for Advancing Translational Sciences (BU-CTSI grant 1UL1TR001430). Dr Mahar is funded by the Fonds de Recherche du Québec–Santé. Dr Cherry is funded by the Alzheimer’s Association (grant AARF-17-529888).
                Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
                Disclaimer: The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official Veterans Affairs or Department of Defense position, policy or decision, unless so designated by other official documentation.
                Additional Contributions: We acknowledge the uncompensated outreach and recruitment contributions of Christopher Nowinski, PhD, from the Concussion Legacy Foundation.
                Article
                PMC6686769 PMC6686769 6686769 noi190059
                10.1001/jamaneurol.2019.2244
                6686769
                31380975
                f4a6b191-72f5-477e-a36b-02a3e1878ae3
                Copyright 2019 American Medical Association. All Rights Reserved.
                History
                : 10 December 2018
                : 28 March 2019
                Categories
                Research
                Research
                Original Investigation
                Featured
                Online First

                Comments

                Comment on this article